ArticleCancer research2015

Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma.

Jian-Jun Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.